||Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002;347（11）:781-9.
||Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352（19）:1977-84.
||Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330（4）:242-8.
||Carter CA, Donahue T, Sun L, et al. Temporarily deferred therapy（watchful waiting）for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era. J Clin Oncol. 2003;21（21）:4001-8.
||Choo R, Klotz L, Danjoux C, et al. Feasibility study:watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol. 2002;167（4）:1664-9.
||Cooperberg MR, Broering JM, Litwin MS, et al. The contemporary management of prostate cancer in the United States:lessons from the cancer of the prostate strategic urologic research endeavor（CapSURE）, a national disease registry. J Urol. 2004;171（4）:1393-401.
||Bacon CG, Giovannucci E, Testa M, et al. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol. 2001;166（5）:1804-10.
||George N. Therapeutic dilemmas in prostate cancer：justification for watchful waiting. Eur Urol. 1998;34 Suppl 3:33-6.
||Kakehi Y. Watchful waiting as a treatment option for localized prostate cancer in the PSA era. Jpn J Clin Oncol. 2003;33（1）:1-5.